NKX2-5 and coronary artery disorder: Specifically, in the context of adult CHD patients carrying NKX2-5 mutations, we envisage that discrete and directed remedies, such as stimulation of cell cycle re-entry and suppression of mitochondrial translation, would augment successful regenerative outcomes.